Exelixis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Exelixis and other ETFs, options, and stocks.

About EXEL

Exelixis, Inc. is an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. 

CEO
Michael M. Morrissey
CEOMichael M. Morrissey
Employees
1,077
Employees1,077
Headquarters
Alameda, California
HeadquartersAlameda, California
Founded
1994
Founded1994
Employees
1,077
Employees1,077

EXEL Key Statistics

Market cap
15.52B
Market cap15.52B
Price-Earnings ratio
19.55
Price-Earnings ratio19.55
Dividend yield
—
Dividend yield—
Average volume
2.56M
Average volume2.56M
High today
$63.74
High today$63.74
Low today
$61.67
Low today$61.67
Open price
$61.84
Open price$61.84
Volume
1.93M
Volume1.93M
52 Week high
$63.74
52 Week high$63.74
52 Week low
$33.76
52 Week low$33.76

Stock Snapshot

Exelixis(EXEL) stock is priced at $63.74, giving the company a market capitalization of 15.52B. It carries a P/E multiple of 19.55.

On 2026-10-20, Exelixis(EXEL) stock moved within a range of $61.67 to $63.74. With shares now at $63.74, the stock is trading +3.4% above its intraday low and 0.0% below the session's peak.

Trading volume for Exelixis(EXEL) stock has reached 1.93M, versus its average volume of 2.56M.

The stock's 52-week range extends from a low of $33.76 to a high of $63.74.

The stock's 52-week range extends from a low of $33.76 to a high of $63.74.

EXEL News

TipRanks 23h
Exelixis price target raised to $65 from $55 at Citizens

Citizens raised the firm’s price target on Exelixis (EXEL) to $65 from $55 and keeps an Outperform rating on the shares. Overall, the firm remains confident in...

Investing.com 1d
Citizens raises Exelixis stock price target to $65 on ESMO data - Investing.com

...

Citizens raises Exelixis stock price target to $65 on ESMO data - Investing.com

Analyst ratings

58%

of 19 ratings
Buy
31.6%
Hold
57.9%
Sell
10.5%

People also own

Based on the portfolios of people who own EXEL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.